JP2002526772A - マトリックスメタロプロテイナーゼ９の診断アッセイおよびその使用 - Google Patents

マトリックスメタロプロテイナーゼ９の診断アッセイおよびその使用

Info

Publication number
JP2002526772A
JP2002526772A JP2000574927A JP2000574927A JP2002526772A JP 2002526772 A JP2002526772 A JP 2002526772A JP 2000574927 A JP2000574927 A JP 2000574927A JP 2000574927 A JP2000574927 A JP 2000574927A JP 2002526772 A JP2002526772 A JP 2002526772A
Authority
JP
Japan
Prior art keywords
mmp
antibody
solid support
free
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000574927A
Other languages
English (en)
Japanese (ja)
Inventor
アリソン ジョイス，
リサ エフ． ウィンシェル，
ローラ デメオ，
ゲイル プロバンチャー，
トーマス イー． ミラー，
クレイグ エム． ソレンセン，
デイビッド イー． ヒル，
Original Assignee
カルバイオケム ノババイオケム コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by カルバイオケム ノババイオケム コーポレイション filed Critical カルバイオケム ノババイオケム コーポレイション
Publication of JP2002526772A publication Critical patent/JP2002526772A/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2000574927A 1998-10-08 1999-10-07 マトリックスメタロプロテイナーゼ９の診断アッセイおよびその使用 Pending JP2002526772A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16852698A 1998-10-08 1998-10-08
US09/168,526 1998-10-08
PCT/US1999/023443 WO2000020860A1 (en) 1998-10-08 1999-10-07 Diagnostic assay for matrix metalloproteinase 9 and use thereof

Publications (1)

Publication Number Publication Date
JP2002526772A true JP2002526772A (ja) 2002-08-20

Family

ID=22611856

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000574927A Pending JP2002526772A (ja) 1998-10-08 1999-10-07 マトリックスメタロプロテイナーゼ９の診断アッセイおよびその使用

Country Status (4)

Country Link
EP (1) EP1038178A1 (de)
JP (1) JP2002526772A (de)
AU (1) AU6511199A (de)
WO (1) WO2000020860A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2244417T3 (es) 1999-04-09 2005-12-16 Rigshospitalet Inhibidor de tejido de metaloproteasa de matriz tipo-1 (timp-1) como un marcador de cancer.
US7374886B2 (en) 1999-04-09 2008-05-20 Rigshospitalet Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancer
FI990888A0 (fi) * 1999-04-20 1999-04-20 Medix Biochemica Ab Oy Menetelmä ja testikittejä respiratorisen alueen tulehduksen läsnäolon ja vaikeusasteen arvioimiseksi
US7094754B2 (en) 2001-08-16 2006-08-22 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7071164B2 (en) 2001-08-16 2006-07-04 Kimberly-Clark Worldwide, Inc. Anti-cancer and wound healing compounds
US6906036B2 (en) 2001-08-16 2005-06-14 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7186693B2 (en) 2001-08-16 2007-03-06 Kimberly - Clark Worldwide, Inc. Metalloproteinase inhibitors for wound healing
US7148194B2 (en) 2002-12-30 2006-12-12 Kimberly-Clark Worldwide, Inc. Method to increase fibronectin
US7189700B2 (en) 2003-06-20 2007-03-13 Kimberly-Clark Worldwide, Inc. Anti-chrondrosarcoma compounds
DK1782068T3 (da) * 2004-07-23 2010-08-02 Ct De Rech Public De La Sante Overvågning af hjertesvigt
WO2009022328A2 (en) * 2007-08-15 2009-02-19 Yeda Research And Development Co. Ltd. Regulators of mmp-9 and uses therof
CN106525793B (zh) * 2016-10-31 2019-06-21 陕西脉元生物科技有限公司 一种利用荧光酶谱印迹技术检测mmp-9的方法
CN114252609A (zh) * 2021-12-23 2022-03-29 武汉生之源生物科技股份有限公司 一种基质金属蛋白酶-9的检测试剂盒及其检测方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324634A (en) * 1992-03-31 1994-06-28 The Research Foundation Of State University Of New York Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer
US5674754A (en) * 1992-10-29 1997-10-07 Bayer Corporation Diagnostic assay for latent matrix metallo-proteinase No. 9 and use thereof in the diagnosis of rheumatoid and inflammatory arthritis and inflammatory bowel disease
US5641636A (en) * 1994-05-20 1997-06-24 University Of Pennsylvania Method of predicting fetal membrane rupture based on matrix metalloproteinase-9 activity
AU6012696A (en) * 1995-06-14 1997-01-15 Aberdeen University Prognostic and therapeutic system for cancer
GB9607287D0 (en) * 1996-04-09 1996-06-12 British Biotech Pharm Diagnosis method

Also Published As

Publication number Publication date
AU6511199A (en) 2000-04-26
WO2000020860A1 (en) 2000-04-13
EP1038178A1 (de) 2000-09-27

Similar Documents

Publication Publication Date Title
US5324634A (en) Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer
US20200057066A1 (en) Non-invasive enzyme screen for tissue remodelling-associated conditions
Hanemaaijer et al. A novel and simple immunocapture assay for determination of gelatinase-B (MMP-9) activities in biological fluids: saliva from patients with Sjögren's syndrome contain increased latent and active gelatinase-B levels
AU2002211697A1 (en) Non-invasive enzyme screen for tissue remodelling-associated conditions
US20020106708A1 (en) Assays reagents and kits for detecting or determining the concentration of analytes
JP2002526772A (ja) マトリックスメタロプロテイナーゼ９の診断アッセイおよびその使用
CN106950382A (zh) 基质金属蛋白酶‑3测定试剂及其制备方法
JP6496322B2 (ja) 酵素の切断活性の検出
Lein et al. Analytical aspects regarding the measurement of metalloproteinases and their inhibitors in blood
Hurewitz et al. Human pleural effusions are rich in matrix metalloproteinases
US7211397B2 (en) Method of analyzing non-complexed forms of prostate specific antigen in a sample to improve prostate cancer detection
JPWO2006123789A1 (ja) 酵素分析方法
US20060154245A1 (en) Method for detecting, screening and/or montoring a cancer in individual
US7482135B2 (en) Proteolytic enzymes in urine as diagnostic parameters in diseases involving matrix remodelling
US20040029200A1 (en) Method and kits for the detection of renal cell carcinoma in a biological fluid of a patient
US11408885B2 (en) Compositions and multiplex assays for characterizing active proteases and their inhibitors
AU667370B2 (en) Process for the detection of complexed cathepsin G and alpha-1-antichymotrypsin
EP1832876A2 (de) Nicht-invasives Enzymsscreeningsverfahren für Gewebeumformungsassoziierte Bedingungen
WO1995000847A1 (en) Immunoassay
WO2000023613A1 (en) A method of assessing a matter associated with parturition in a pregnant individual
Wilson Medical Laboratory Science
Sheet HUMAN MATRIX METALLOPROTEINASE-9 ELISA
JPH1094400A (ja) 臓器移植後の慢性拒絶反応の検査方法及び尿中の成分の測定方法